Autopsy report · NCT04431193
Estimate Serum Oxytocin PD Range in the Periphery
Cause of deathOther
“Study will be replaced by a revised study protocol”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Conditions
- Osteoarthritis, Knee
- Interventions
- Oxytocin
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria
“Substantially redesigning study protocol and opening a new study in the future.” - Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses
“The study protocol needed to be modified” - Study of Stored Tumor Samples in Young Patients With Brain Tumors
“New Protocol that replaces the current study” - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
“study revised and reinitiated under another protocol” - OsseoFit™ Prospective Data Collection
“Planning new study protocol”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.